Title: The usefulness of a seven-subtest and four-subtest short form of the WAIS in clinical practice

Biography:

Maria Lindau is licensed psychology and PhD in medicin, for many years she has worked as a clinical neuropsychologist in Sweden at Karolinska Huddinge - Karolinska Universitetssjukhuset and at Akademiska sjukhuset, Uppsala.  The last decade she serves as an assistant professor in neuropsychology at the Dept. of Psychology, Stockholm University. Her research focus is on major and mild neurocognitive disorders (dementia/MCI), as well as on psychometrics.

Abstract

The Wechsler Adult Intelligence Scale (WAIS) is an American scale and is one of the internationally most frequently applied neuropsychological (nps) measures for the assessment of cognitive levels in e.g. suspected neurodegenerative disorders, neuropsychiatric conditions as well as in non-clinical cases.  Despite its popularity (Crawford, et al., 2008), one well known drawback with this instrument is the administration time, which amounts to 3-4 hours (Ryan, et al., 2015). Therefore, ever since the early days of the WAIS-scale (in the 1940s), short forms encompassing 2-8 subtests have been published (Úbeda, et al. , 2016; Denney, et al.,   2015). The seven-subtest short form of the WAIS (7-scale), encompassing the subtests Information, Digit Span, Arithmetic (AR), Similarities (SI), Picture Completion, Block Design (BD)  and Coding (CD)  (Meyers, et al., 2013) is often used in Sweden, but has up to know not been validated in a Swedish context.

The purpose was to investigate whether the 7-scale was statistically valid to apply to the Swedish adaptation of the WAIS-IV, the possibilities of a further reduction of the 7-scale and the usefulness of shortened scales in clinical differential diagnosis.  

Methodology: Nps assessment (WAIS) of 218 healthy individuals (aged 18-73) and nps assessment with the full scale WAIS of a clinical sample, n=145, including vascular disorders (stroke, hemorrhages), tumors, head trauma and multiple sclerosis. Statistics: Linear regression and discriminant analysis. 

Preliminary findings:  Linear regression indicated that the 7-scale    explained 93.1 % of the variance of FSIQ, and that the best reduction of this model was a set of four tests (4-scale): AR, SI, BD, CD, predicting FSIQ with an 87.6% certainty, and representing the WAIS-scale all four indices. In the clinical sample 92.1% of the FSIQ variance was explained by the 4-model. Pairwise analysis of the disease groups with discriminant analysis showed that only the trauma and vascular groups were possible to significantly distinguish (p=. 013) and that 62.0  % were correctly classified.   The sensitivity for the trauma group was 68%, the specificity 75.6%. In the vascular group the sensitivity was 82% and the specificity 98%. Clinical application of the 7-scale is under ongoing analysis.